Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Glenmark Generics, a subsidiary of Glenmark Pharmaceuticals, has received ANDA approval from the FDA for Trandolapril tablets USP 1mg, 2mg and 4mg and will immediately commence marketing and distribution of these products in the US market.
Subscribe to our email newsletter
Glenmark’s Trandolapril is an angiotensin converting enzyme inhibitor used to treat high blood pressure and is the generic equivalent of Mavik tablets marketed by Abbott Laboratories.
This recent approval coupled with the three abbreviated new drug application approvals received from the FDA in May 2008 for Mometasone cream USP 0.1%, Mometasone ointment USP 0.1% and Metformin tablets USP 500mg, 850mg, 1000mg brings Glenmark’s current portfolio to 33 generic products authorized for distribution in the US market.